- Home
- BTSG vs SLNO Comparison
BTSG vs SLNO Comparison
Compare BTSG & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTSG
- SLNO
- Stock Information
- Founded
- BTSG 1974
- SLNO 1999
- Country
- BTSG United States
- SLNO United States
- Employees
- BTSG N/A
- SLNO N/A
- Industry
- BTSG
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BTSG
- SLNO Health Care
- Exchange
- BTSG NYSE
- SLNO Nasdaq
- Market Cap
- BTSG 4.1B
- SLNO 3.8B
- IPO Year
- BTSG 2024
- SLNO 2014
- Fundamental
- Price
- BTSG $22.53
- SLNO $82.17
- Analyst Decision
- BTSG Strong Buy
- SLNO Strong Buy
- Analyst Count
- BTSG 9
- SLNO 9
- Target Price
- BTSG $23.50
- SLNO $103.33
- AVG Volume (30 Days)
- BTSG 3.3M
- SLNO 1.0M
- Earning Date
- BTSG 08-01-2025
- SLNO 08-06-2025
- Dividend Yield
- BTSG N/A
- SLNO N/A
- EPS Growth
- BTSG N/A
- SLNO N/A
- EPS
- BTSG 0.29
- SLNO N/A
- Revenue
- BTSG $11,858,835,000.00
- SLNO N/A
- Revenue This Year
- BTSG $11.55
- SLNO N/A
- Revenue Next Year
- BTSG $12.14
- SLNO N/A
- P/E Ratio
- BTSG $78.00
- SLNO N/A
- Revenue Growth
- BTSG 30.55
- SLNO N/A
- 52 Week Low
- BTSG $10.15
- SLNO $39.41
- 52 Week High
- BTSG $25.57
- SLNO $86.79
- Technical
- Relative Strength Index (RSI)
- BTSG 54.00
- SLNO 59.70
- Support Level
- BTSG $22.48
- SLNO $82.41
- Resistance Level
- BTSG $23.78
- SLNO $86.79
- Average True Range (ATR)
- BTSG 0.70
- SLNO 2.94
- MACD
- BTSG 0.04
- SLNO 0.17
- Stochastic Oscillator
- BTSG 72.94
- SLNO 60.94
About BTSG BRIGHTSPRING HEALTH SERVICES INC
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.